Pharmacokinetics of the new potential antiparkinsonian agent ADK-1113 after different dosage regimens in mice
The pharmacokinetics of ADK-1113 were studied in mice treated with different dosage regimens.Objective. This study aimed to investigate ADK-1113 pharmacokinetics after multiple intraperitoneal administrations.Methods. This study was conducted on male outbred mice. The concentrations of ADK-1113 in t...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
LLC “Publisher OKI”
2025-08-01
|
| Serie: | Фармакокинетика и Фармакодинамика |
| Soggetti: | |
| Accesso online: | https://www.pharmacokinetica.ru/jour/article/view/459 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|